New Drug IBI3009 for Advanced Small Cell Lung Cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new drug called IBI3009 for people with advanced small cell lung cancer that cannot be removed by surgery. It aims to see how safe the drug is and how well it works against the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 75 years old for the first part of the trial.
- You have small cell lung cancer that cannot be surgically removed, has spread, or is in an advanced stage.
- You are able to take care of yourself and do daily activities (ECOG score 0 or 1).
- You must not be pregnant or breastfeeding, and agree to use birth control if needed.
- Any side effects from past treatments should be mostly resolved before starting the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding IBB0979 (an experimental immunotherapy) to standard chemotherapy (topotecan) works better than topotecan alone for people whose small cell lung cancer has returned or worsened after prior treatment. It aims to find a new option for patients who have limited options.
This Phase 2 trial tests how well two study drugs (and a combination of them) work in people with extensive-stage small cell lung cancer. It’s mainly for patients whose cancer has come back or who couldn’t tolerate at least some standard treatments, and it aims to see if treatment can shrink tumors and be tolerable.
This trial tests a combination of two drugs (adebelizumab and irinotecan liposome) for people with advanced small cell lung cancer that got worse after first-line treatment. It aims to see if this combination works better and to find out which patients benefit the most.
This trial tests a new drug called IBI3001 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and effective against different types of cancer.
This early-stage trial tests a new immunotherapy drug called BI115 in people with advanced small cell lung cancer (a fast-growing type of lung cancer). The study will check if the drug is safe and whether it helps slow or shrink the cancer.
This trial tests a new drug called IBI363 for people with extensive-stage small cell lung cancer whose cancer has continued to grow after immunotherapy and other treatments. It aims to see if IBI363 can help shrink tumors or slow the disease.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.